BFS Equipment Streamlines the Packaging Process - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

BFS Equipment Streamlines the Packaging Process
Aseptic blow–fill–seal minimizes human intervention in the packaging process.


Pharmaceutical Technology
Volume 34, Issue 4, pp. 38-46


Hallie Forcinio
The aseptic blow–fill–seal (BFS) process blow-molds unit- or multidose containers, fills sterile product, and hermetically seals the package in one highly automated machine. Because the BFS process eliminates human interventions in the filling environment, the biggest source of contamination, makers of ophthalmic, inhalation, and parenteral products such as biologics and vaccines find BFS technology appealing.

In fact, the US Pharmacopeia considers aseptic BFS to be an advanced aseptic process (1). "Aseptic BFS systems offer a unique combination of flexibility in packaging design, low operating cost, and a high degree of sterility assurance," explains Chuck Reed, director of sales and marketing at Weiler Engineering, (Elgin, IL), in a white paper titled "Advances in Aseptic Blow–Fill–Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety."

The blow-molding process itself helps achieve high sterility-assurance levels because it produces a container that is free of viable micro-organisms and endotoxins. Reed's white paper cites a study that shows fractional spore-contamination levels of less than 1 × 10–6 and a three-log reduction in endotoxins. The probability that the blow-molding process will create a nonsterile unit is roughly 1 in 1,000,000 (2).

The BFS process consists of the following five completely automated steps (3–4):
  • Step 1: Thermoplastic resin such as high-density polyethylene or polypropylene is melted and extruded into a tubular shape or parison.
  • Step 2: When the parison reaches the proper length, the mold closes and the parison is cut. The bottom is pinched shut, the top is held in place, and the mold is positioned under the blowing and filling nozzle.
  • Step 3: The blow–fill nozzle descends into the mold and expands the parison with a jet of sterile compressed air or vacuum. Once the container is formed against the mold, the nozzle precisely fills sterile product into the container.
  • Step 4: Separate sealing molds close to form the top and hermetically seal the container.
  • Step 5: The mold opens and the sealed container exits the machine for inspection, labeling, and cartoning.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: Pharmaceutical Technology,
Click here